The effectiveness of the combination of PI3K and MEK inhibitors with radiotherapy in our study is in line with the data obtained by Williams et al. [42] using pancreatic cancer cells treated with a similar strategy. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.